Abel Hall LLC’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$253K Buy
12,340
+73
+0.6% +$1.67K 0.04% 585
2026
Q1
$270K Buy
12,267
+1,369
+13% +$23.8K 0.06% 463
2025
Q4
$128K Buy
+10,898
New +$140K 0.03% 590

Other funds holding CC

Abel Hall LLC's CC Position: Q2 2026 in Review

Abel Hall LLC increased its Chemours (CC) stake by 0.6% in Q2 2026, buying an estimated $1.67K and bringing the position to 12,340 shares worth $253K. The position accounts for 0.04% of the portfolio, ranked #585.

Abel Hall LLC first reported a position in CC in Q4 2025 and has held it in 3 quarters since. The position peaked at $270K in Q1 2026. 136 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Abel Hall LLC held 12,340 shares of Chemours worth $253K as of Q2 2026.
  • Abel Hall LLC bought 73 Chemours shares in Q2 2026, an estimated $1.67K.
  • Chemours made up 0.04% of Abel Hall LLC's portfolio in Q2 2026, its #585 holding.
  • Abel Hall LLC first reported a position in Chemours in Q4 2025 and has held it in 3 quarters since.
  • Abel Hall LLC's Chemours position peaked at $270K in Q1 2026.
  • 136 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.